Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Hartung

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Pharmacoepidemiology and Drug Safety|October 22, 2013
Characteristics and trends of low-dose quetiapine use in two western state Medicaid programsDaniel M Hartung, Judy Zerzan, Traci Yamashita, et al.
Annals of Internal Medicine|April 2, 2014
Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publicationsDaniel M Hartung, Deborah A Zarin, Jeanne-Marie Guise, et al.
Annals of Family Medicine|September 17, 2010
Effect of drug sample removal on prescribing in a family practice clinicDaniel M Hartung, David Evans, Dean G Haxby, et al.
Annals of the Rheumatic Diseases|January 25, 2018
Elephant in the roomDaniel M Hartung, Kirbee Johnston, David M Cohen, et al.
JAMA Internal Medicine|September 12, 2017
Trends and Characteristics of US Medicare Spending on Repository CorticotropinDaniel M Hartung, Kirbee Johnston, Shelby Van Leuven, et al.
Journal of Addiction Medicine|August 1, 2020
Patterns of Prescription Opioid Use Prior to Self-reported Heroin InitiationDaniel M Hartung, Jonah Geddes, Kirbee A Johnston, et al.
Psychiatric Services (Washington, D.C.)|September 4, 2013
Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid populationDaniel M Hartung, Luke Middleton, Bentson H McFarland, et al.
Harm Reduction Journal|March 21, 2025
Pharmacy-related syringe access barriers: an audit of Oregon community pharmaciesVictor Abreu, Marissa McGinnis, Savannah Justen, et al.
Journal of Substance Abuse Treatment|October 3, 2021
Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin onlySanae El Ibrahimi, Sara Hallvik, Kirbee Johnston, et al.
Pharmacoepidemiology and Drug Safety|July 30, 2020
Opioid prescribing on discharge to skilled nursing facilitiesAshlee R Hubsky, Brie N Noble, Daniel M Hartung, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Pharmacoepidemiology and Drug Safety|October 22, 2013
Characteristics and trends of low-dose quetiapine use in two western state Medicaid programsDaniel M Hartung, Judy Zerzan, Traci Yamashita, et al.
Annals of Internal Medicine|April 2, 2014
Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publicationsDaniel M Hartung, Deborah A Zarin, Jeanne-Marie Guise, et al.
Annals of Family Medicine|September 17, 2010
Effect of drug sample removal on prescribing in a family practice clinicDaniel M Hartung, David Evans, Dean G Haxby, et al.
Annals of the Rheumatic Diseases|January 25, 2018
Elephant in the roomDaniel M Hartung, Kirbee Johnston, David M Cohen, et al.
JAMA Internal Medicine|September 12, 2017
Trends and Characteristics of US Medicare Spending on Repository CorticotropinDaniel M Hartung, Kirbee Johnston, Shelby Van Leuven, et al.
Journal of Addiction Medicine|August 1, 2020
Patterns of Prescription Opioid Use Prior to Self-reported Heroin InitiationDaniel M Hartung, Jonah Geddes, Kirbee A Johnston, et al.
Psychiatric Services (Washington, D.C.)|September 4, 2013
Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid populationDaniel M Hartung, Luke Middleton, Bentson H McFarland, et al.
Harm Reduction Journal|March 21, 2025
Pharmacy-related syringe access barriers: an audit of Oregon community pharmaciesVictor Abreu, Marissa McGinnis, Savannah Justen, et al.
Journal of Substance Abuse Treatment|October 3, 2021
Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin onlySanae El Ibrahimi, Sara Hallvik, Kirbee Johnston, et al.
Pharmacoepidemiology and Drug Safety|July 30, 2020
Opioid prescribing on discharge to skilled nursing facilitiesAshlee R Hubsky, Brie N Noble, Daniel M Hartung, et al.
Pageof 11